ATE270707T1 - Entepneumovirus und entsprechendes impfstoff - Google Patents

Entepneumovirus und entsprechendes impfstoff

Info

Publication number
ATE270707T1
ATE270707T1 AT00988869T AT00988869T ATE270707T1 AT E270707 T1 ATE270707 T1 AT E270707T1 AT 00988869 T AT00988869 T AT 00988869T AT 00988869 T AT00988869 T AT 00988869T AT E270707 T1 ATE270707 T1 AT E270707T1
Authority
AT
Austria
Prior art keywords
entepneumovirus
corresponding vaccine
avian
vaccine
pneumovirosis
Prior art date
Application number
AT00988869T
Other languages
English (en)
Inventor
Sylvain Gabriel Goutebroze
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE270707T1 publication Critical patent/ATE270707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Loading And Unloading Of Fuel Tanks Or Ships (AREA)
  • Peptides Or Proteins (AREA)
AT00988869T 1999-11-26 2000-11-22 Entepneumovirus und entsprechendes impfstoff ATE270707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914952A FR2801607B1 (fr) 1999-11-26 1999-11-26 Pneumovirus du canard et vaccins correspondants
PCT/FR2000/003255 WO2001038497A1 (fr) 1999-11-26 2000-11-22 Pneumovirus du canard et vaccins correspondants

Publications (1)

Publication Number Publication Date
ATE270707T1 true ATE270707T1 (de) 2004-07-15

Family

ID=9552613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988869T ATE270707T1 (de) 1999-11-26 2000-11-22 Entepneumovirus und entsprechendes impfstoff

Country Status (6)

Country Link
US (1) US6919084B2 (de)
EP (1) EP1232249B1 (de)
AT (1) ATE270707T1 (de)
DE (1) DE60012042T2 (de)
FR (1) FR2801607B1 (de)
WO (1) WO2001038497A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040002853A (ko) 2001-01-19 2004-01-07 비로노바티브 비.브이. 감응성 포유류에서 호흡계 질환을 유발하는 바이러스
US8715922B2 (en) 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
EP1485468A4 (de) 2002-02-21 2007-01-03 Medimmune Vaccines Inc Rekombinante parainfluenzavirus-expressionssysteme und impfstoffe mit aus metapneumovirus stammenden heterologen antigenen
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
CN101410519B (zh) 2003-04-25 2013-04-24 免疫医疗有限责任公司 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
JP4976376B2 (ja) * 2005-04-08 2012-07-18 メディミューン，エルエルシー 哺乳動物メタニューモウイルスに対する抗体
CN101374547A (zh) * 2005-12-22 2009-02-25 财团法人化学及血清疗法研究所 卵内接种用疫苗
EP3542815A1 (de) 2008-11-28 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Rekombinanter vogelgrippeimpfstoff und verwendungen davon
EP2414386B1 (de) 2009-04-03 2016-01-27 Merial Limited Vogelimpfstoffe mit newcastle-krankheit-vektor
PL2467158T3 (pl) 2009-08-21 2017-07-31 Merial, Inc. Rekombinowana szczepionka z paramyksowirusem ptaków oraz sposób jej wytwarzania i zastosowania
US10633667B2 (en) 2009-12-28 2020-04-28 Boehringer Ingelheim Animal Health USA Inc. Recombinant NDV antigen and uses thereof
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
ES2617743T3 (es) 2010-03-12 2017-06-19 Merial, Inc. Vacunas recombinantes del virus de la lengua azul y sus utilizaciones
EP2611460B1 (de) 2010-08-31 2016-10-05 Merial, Inc. Auf das virus der newcastle-krankheit gerichtete herpesvirus-impfstoffe
CN102166029A (zh) * 2011-05-05 2011-08-31 陈明科 一种仙草多菌养生精功能饮料
CA2837582C (en) 2011-05-27 2021-03-02 Merial Limited Genetic vaccines against hendra virus and nipah virus
SI2814508T1 (sl) 2012-02-14 2017-10-30 Merial, Inc. Rotavirusna podenotska cepiva ter postopki njihove izdelave in uporaba
EP2861248B1 (de) 2012-06-13 2017-11-15 Merial, Inc. Impfstoffe aus reassortierendem btv und ahsv
CN104995315A (zh) 2012-12-18 2015-10-21 梅里亚股份有限公司 Ibv、csfv和ndv的高分辨熔解基因分型
ES3050936T3 (en) 2015-06-23 2025-12-23 Boehringer Ingelheim Vetmedica Gmbh Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
HUE065661T2 (hu) 2015-09-29 2024-06-28 Boehringer Ingelheim Animal Health Usa Inc Kutya parvovírus (CPV) vírusszerû részecske (VLP) vakcinák és alkalmazásuk
WO2017087550A1 (en) 2015-11-16 2017-05-26 Georgia State University Research Foundation, Inc. Tunable vaccine platform against pathogens of the paramyxovirus family
DK3380119T3 (da) 2015-11-23 2021-11-15 Boehringer Ingelheim Animal Health Usa Inc Fmdv- og e2-fusionsproteiner og anvendelser deraf
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
EP3439690A2 (de) 2016-04-07 2019-02-13 Merial, Inc. Herzwurmimpfstoff, verfahren und verwendungen davon
CN107653231B (zh) * 2017-09-28 2021-02-23 河南科技学院 鸭源性冠状病毒弱毒株ibvdcv35及其应用
CN113384692A (zh) * 2020-12-28 2021-09-14 哈药集团生物疫苗有限公司 鸭呼肠弧病毒、鸭圆环病毒二联灭活疫苗及其制备方法
CN114209821A (zh) * 2021-12-30 2022-03-22 哈药集团生物疫苗有限公司 防治鸭圆环病毒病、新型鸭呼肠孤病毒病和鸭腺病毒病3型的三联灭活疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602791B1 (fr) * 1986-08-18 1988-11-10 Ministere Agri Direction Quali Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
DE3878982T2 (de) * 1987-05-21 1993-07-22 Know How Licensors Ltd Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
US6605460B1 (en) * 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine

Also Published As

Publication number Publication date
FR2801607A1 (fr) 2001-06-01
DE60012042T2 (de) 2005-07-07
EP1232249B1 (de) 2004-07-07
EP1232249A1 (de) 2002-08-21
WO2001038497A1 (fr) 2001-05-31
FR2801607B1 (fr) 2001-12-28
DE60012042D1 (de) 2004-08-12
US20020192234A1 (en) 2002-12-19
US6919084B2 (en) 2005-07-19

Similar Documents

Publication Publication Date Title
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
NO20015073D0 (no) Vaksiner
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE60012711D1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
UY26555A1 (es) Composición farmacéutica para modulación inmunológica y preparación de vacunas
CY1107457T1 (el) Εμβoλιο κατa του hpv
NL300415I1 (nl) Vaccin tegen antigenen van bacteriën
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
HUP0301180A2 (hu) Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban
CY1113826T1 (el) Ανοσοενισχυτικα για εμβολια
WO2003051392A3 (en) Streptococcus pneumoniae vaccine
DK1259259T3 (da) Mucosal adjuvansformulering
EP1322326A4 (de) Gegen das angeborene immunsystem gerichtete impfstoffe
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
WO2000061766A3 (en) Telomerase-specific cancer vaccine
WO2001022994A3 (en) Vaccines against neisseria infection
WO2005048918A3 (en) Anthrax vaccine
FR2796282B1 (fr) Vaccin inactive contre la calicivirose feline
WO2002070004A3 (en) Papillomavirus vaccines
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
DE60036705D1 (de) Adjuvanskombinationen zur immunisierung und vakzine
DE60121035D1 (de) Impfstoff zur Behandung von Nikotinabhängigkeit
WO2002030458A8 (en) Yersinia adhesion protein as vaccine adjuvant
WO2002072622A3 (en) Vaccine antigens against infection by chlamydia trachomatis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties